KHAN, M.A. et al. 2025. QBD-DRIVEN DESIGN AND PHARMACOKINETIC PROFILING OF REMOGLIFLOZIN ETABONATE SUSTAINED-RELEASE MATRIX TABLETS FOR DIABETES MANAGEMENT. International Journal of Applied Pharmaceutics. 18, 1 (Oct. 2025). DOI:https://doi.org/10.22159/ijap.2026v18i1.56445.